Skip to the card

2026-11-22 issue

Observed arrival · 2026-11-22

A dated price board for self-pay GLP-1s

selfpayindex.com Visit website
Editorial interest 82/100 Selection signal · not a rating of the site

A public comparison of self-pay prices for FDA-approved GLP-1 medicines, with source links and read dates for each listed figure.

Landing page captured for the 2026-11-22 issue.
For
People comparing self-pay costs for FDA-approved GLP-1 medicines
Worth noticing
Rows older than 30 days are hidden by default, and each displayed price links to a named first-party source.

Field notes

The comparison names manufacturer sources including LillyDirect and NovoCare, gives strength or formulation details where shown, and marks Saxenda and Rybelsus as unverified rather than supplying a number. Its stated rules limit coverage to FDA-approved products and require a named first-party source and reading date. A separate section explains what TrumpRx is and emphasizes that the site is not affiliated with a government agency.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central

One card from the complete issue

The Case Against a Second Horse

291,159 arrived 1,000 judged 983 catalogued Enter the complete issue
selfpayindex.com

Landing page observed 2026-11-22. The live site may have changed.